Patricia Ann Duffy

Array ( [id] => 4236843 [patent_doc_number] => 06080549 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-06-27 [patent_title] => 'Methods and materials for the diagnosis and treatment of schizophrenia and related disorders' [patent_app_type] => 1 [patent_app_number] => 8/833703 [patent_app_country] => US [patent_app_date] => 1997-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 5401 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 223 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/080/06080549.pdf [firstpage_image] =>[orig_patent_app_number] => 833703 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3804660 [patent_doc_number] => 05854006 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-29 [patent_title] => 'Gamma-glutamyl transpeptidase-specific antibody, prodrugs for the treatment of gamma-glutamyl transpeptidase-expressing tumors, and methods of administration thereof' [patent_app_type] => 1 [patent_app_number] => 8/825349 [patent_app_country] => US [patent_app_date] => 1997-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 13 [patent_no_of_words] => 8796 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/854/05854006.pdf [firstpage_image] =>[orig_patent_app_number] => 825349 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4062097 [patent_doc_number] => 05866412 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-02 [patent_title] => 'Chromosome 18 marker' [patent_app_type] => 1 [patent_app_number] => 8/828007 [patent_app_country] => US [patent_app_date] => 1997-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 23150 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/866/05866412.pdf [firstpage_image] =>[orig_patent_app_number] => 828007 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1503074 [patent_doc_number] => 06465210 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-15 [patent_title] => 'Nucleic acid molecules encoding CASPR/p190' [patent_app_type] => B1 [patent_app_number] => 08/826134 [patent_app_country] => US [patent_app_date] => 1997-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 38075 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/465/06465210.pdf [firstpage_image] =>[orig_patent_app_number] => 08826134 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4129640 [patent_doc_number] => 06121003 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-09-19 [patent_title] => 'Monoclonal antibodies specific for an epitope of phosphorylated tau, and their use' [patent_app_type] => 1 [patent_app_number] => 8/776404 [patent_app_country] => US [patent_app_date] => 1997-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10870 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/121/06121003.pdf [firstpage_image] =>[orig_patent_app_number] => 776404 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4246203 [patent_doc_number] => 06221670 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-24 [patent_title] => 'Methods to identify .beta.-amyloid reducing agents' [patent_app_type] => 1 [patent_app_number] => 8/821876 [patent_app_country] => US [patent_app_date] => 1997-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 6 [patent_no_of_words] => 7994 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 137 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/221/06221670.pdf [firstpage_image] =>[orig_patent_app_number] => 821876 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4228040 [patent_doc_number] => 06117424 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-09-12 [patent_title] => 'Compositions of mononuclear phagocytes useful for promoting axonal regeneration' [patent_app_type] => 1 [patent_app_number] => 8/818818 [patent_app_country] => US [patent_app_date] => 1997-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 19 [patent_no_of_words] => 8905 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/117/06117424.pdf [firstpage_image] =>[orig_patent_app_number] => 818818 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1357384 [patent_doc_number] => 06573066 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-06-03 [patent_title] => 'FtsH from Staphylococcus aureus' [patent_app_type] => B1 [patent_app_number] => 08/816177 [patent_app_country] => US [patent_app_date] => 1997-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12840 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/573/06573066.pdf [firstpage_image] =>[orig_patent_app_number] => 08816177 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4407000 [patent_doc_number] => 06300093 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-09 [patent_title] => 'Islet cell antigen 1851' [patent_app_type] => 1 [patent_app_number] => 8/811481 [patent_app_country] => US [patent_app_date] => 1997-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35040 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 112 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/300/06300093.pdf [firstpage_image] =>[orig_patent_app_number] => 811481 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4046370 [patent_doc_number] => 05968778 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-19 [patent_title] => 'PDGF-AB, preparation process and pharmaceuticals containing them' [patent_app_type] => 1 [patent_app_number] => 8/804953 [patent_app_country] => US [patent_app_date] => 1997-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 8 [patent_no_of_words] => 7117 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 150 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/968/05968778.pdf [firstpage_image] =>[orig_patent_app_number] => 804953 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1542106 [patent_doc_number] => 06372453 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-16 [patent_title] => 'Neurturin receptor' [patent_app_type] => B1 [patent_app_number] => 08/802805 [patent_app_country] => US [patent_app_date] => 1997-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 27 [patent_no_of_words] => 42995 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/372/06372453.pdf [firstpage_image] =>[orig_patent_app_number] => 08802805 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4126067 [patent_doc_number] => 06120774 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-09-19 [patent_title] => 'Heterophil-adapted poultry vaccine' [patent_app_type] => 1 [patent_app_number] => 8/801722 [patent_app_country] => US [patent_app_date] => 1997-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5389 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/120/06120774.pdf [firstpage_image] =>[orig_patent_app_number] => 801722 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1174669 [patent_doc_number] => 06746859 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-06-08 [patent_title] => 'Cloning of enterokinase and method of use' [patent_app_type] => B1 [patent_app_number] => 08/794042 [patent_app_country] => US [patent_app_date] => 1997-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 12614 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/746/06746859.pdf [firstpage_image] =>[orig_patent_app_number] => 08794042 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3939791 [patent_doc_number] => 05981508 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-09 [patent_title] => 'Facilitation of repair of neural injury with CM101/GBS toxin' [patent_app_type] => 1 [patent_app_number] => 8/791857 [patent_app_country] => US [patent_app_date] => 1997-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 14 [patent_no_of_words] => 4874 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/981/05981508.pdf [firstpage_image] =>[orig_patent_app_number] => 791857 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4105531 [patent_doc_number] => 06022710 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-08 [patent_title] => 'Nucleic acid encoding greA from Streptococcus pneumoniae' [patent_app_type] => 1 [patent_app_number] => 8/788806 [patent_app_country] => US [patent_app_date] => 1997-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 16070 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/022/06022710.pdf [firstpage_image] =>[orig_patent_app_number] => 788806 [rel_patent_id] =>[rel_patent_doc_number] =>)